
Pagmet OD 1500mcg/75mg Tablet SR
Marketer
Cubit Healthcare
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Pagmet OD 1500mcg/75mg Tablet SR
Neurax SR 1500mcg/75mg tablets are a prescription medication managing neuropathic pain. Its mechanism involves modulating nerve cell calcium channels to reduce pain signals. The medication also offers neuroprotective effects, promoting nerve fiber repair. Neurax SR is administered orally, with or without food, ideally before sleep, consistently at the same time daily for optimal therapeutic levels. Always adhere to your physician's prescribed dosage and duration, as this medication has addictive potential. Missed doses should be taken immediately upon recall. Complete the entire treatment course, even with symptom improvement. Abrupt cessation is strongly discouraged without consulting your doctor. Common, generally mild and transient, side effects may include upper respiratory irritation, increased hunger, elevated mood, trembling, visual blurring, dry mouth, lightheadedness, and drowsiness. Avoid activities requiring alertness until the medication's effects are known. Weight gain is possible; a balanced diet and exercise are recommended. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Full disclosure of all other medications is crucial, as interactions may compromise efficacy or alter the drug's action. Disclose pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of Pagmet OD 1500mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of Pagmet OD 1500mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Pagmet OD 1500mcg/75mg sustained-release tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Pagmet OD 1500mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Pagmet OD 1500mcg/75mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pagmet OD 1500mcg/75mg Extended-Release tablets can be consumed with or without food, though consistent daily timing is recommended.
How Pagmet OD 1500mcg/75mg Tablet SR works:
Each Pagmet OD 1500mcg/75mg sustained-release tablet unites methylcobalamin, a vitamin B variant crucial for myelin production (the protective sheath around nerves), and pregabalin, an alpha-2-delta ligand. Methylcobalamin aids nerve fiber protection and repair, while pregabalin's action on nerve cell calcium channels reduces pain signals. This synergistic effect provides relief from neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Pagmet OD 1500mcg/75mg extended-release tablets and alcohol may result in pronounced sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Pagmet OD 1500mcg/75mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Pagmet OD 1500mcg/75mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Pagmet OD 1500mcg/75mg SR tablets may cause drowsiness, blurred vision, and dizziness. Driving is inadvisable if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Pagmet OD 1500mcg/75mg extended-release tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pagmet OD 1500mcg/75mg Tablet SR in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Pagmet OD 1500mcg/75mg Tablet SR :
Should you forget a dose of Pagmet OD 1500mcg/75mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pagmet OD 1500mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
